Literature DB >> 8226406

Antibiotic guidelines and antibiotic utilization in Dutch hospitals.

E Stobberingh1, R Janknegt, G Wijnands.   

Abstract

In April-May 1991 the availability of antibiotic formularies in Dutch hospitals was analysed as well as data available on antibiotic susceptibility patterns. In addition data on the use of different groups of antimicrobial agents (aminoglycosides, beta-lactam compounds including aztreonam and imipenem, co-trimoxazole, vancomycin and fluoroquinolones) were collected by a questionnaire. Thirty-eight formularies were received which were used in 78 hospitals. No formulary was available from 31 hospitals: 15 hospitals did not intend to set up antibiotic guidelines, nine hospitals were using their first formulary and seven used a revised version of the existing one. Fifteen formularies dated from 1987 or earlier. The availability of antibiotic susceptibility patterns ranged from no data at all (n = 14) to extensive data per species, per agent and per ward (n = 5). From 20 hospitals data on antibiotic usage as well as on antibiotic guidelines were obtained. Because several hospitals used the same formulary, 15 different formularies were analysed from 20 hospitals. Fluoroquinolones were used in all hospitals, but were only mentioned in the formularies of six hospitals. The data in the present study underscore the need for a collaborative approach of medical staff, hospital pharmacy and microbiologist in order to maintain a relatively low level of antibiotic resistance in Dutch hospitals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226406     DOI: 10.1093/jac/32.1.153

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Antimicrobial utilization and bacterial resistance at three different hospitals.

Authors:  V Vlahović-Palcevski; M Morović; G Palcevski; L Betica-Radić
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Appropriateness of antimicrobial therapy measured by repeated prevalence surveys.

Authors:  Ina Willemsen; Anneke Groenhuijzen; Diana Bogaers; Arie Stuurman; Peter van Keulen; Jan Kluytmans
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

3.  Antibiotics utilization during the war period: influence of drug donations.

Authors:  V Vlahović Palcevski; D Vitezić; G Palcevski
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

Review 4.  Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines.

Authors:  D A Davis; A Taylor-Vaisey
Journal:  CMAJ       Date:  1997-08-15       Impact factor: 8.262

Review 5.  Fluoroquinolones: use of clinical data to aid formulary choice by the system of objective judgement analysis (SOJA) method.

Authors:  R Janknegt
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

Review 6.  Risk factors for acquisition of multiply drug-resistant gram-negative bacteria.

Authors:  I M Gould
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

7.  Treatment of urinary tract infections in Dutch hospitals.

Authors:  E Stobberingh; R Janknegt; W J Wijnands
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

8.  Oral cephalosporins for use in a parenteral-to-oral switch programme.

Authors:  D M Rimmer
Journal:  Infection       Date:  1995       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.